PRELUDE CAPITAL MANAGEMENT, LLC

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1387508 NEW YORK, NY

Back to LFCR Full portfolio

Position in LFCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$59,534

-$94,470 QoQ

Shares Held

16,004

-15.0% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. LFCR ranks #16 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	154,970	$4,667,696
2	ETON	Eton Pharmaceuticals, Inc.	188,802	$4,659,633
3	CRON	Cronos Group Inc.	1,500,000	$3,765,000
4	LQDA	Liquidia Corp	40,595	$1,532,055
5	UTHR	UNITED THERAPEUTICS Corp	2,345	$1,390,538
6	VTRS	Viatris Inc	102,186	$1,380,532
7	PCRX	Pacira BioSciences, Inc.	50,735	$1,146,611
8	ALKS	Alkermes plc.	16,928	$598,574

All Filings in LFCR

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$59,534	16,004	-15.0%	Shares	Other	2026-05-15
2025-12-31	$154,004	18,827	+43.8%	Shares	Other	2026-02-17
2025-06-30	$106,339	13,096	-45.4%	Shares	Other	2025-08-14
2025-03-31	$168,727	23,967	+64.3%	Shares	Other	2025-05-15
2024-12-31	$108,373	14,586	-47.0%	Shares	Other	2025-02-14
2024-09-30	$135,594	27,504	+20.9%	Shares	Other	2024-11-14
2023-12-31	$140,791	22,745	+6.8%	Shares	Other	2024-02-14
2023-03-31	$80,495	21,295	—	Shares	Other	2023-06-01
No filing history on record for this holder in this stock.